Functional expression of TRAIL receptors TRAIL-R1 and TRAIL-R2 in esophageal adenocarcinoma
Authors:
- Mamoun YounesMYMamoun Younes
- Georgios V. GeorgakisGGGeorgios V. Georgakis
- Mahdis RahmaniMRMahdis Rahmani
- David BeerDBDavid Beer
- Anas YounesAYAnas Younes
- 31 March 2006
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 42 (4) , 542-547
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivoBritish Journal of Cancer, 2005
- Induction of Tumor-specific T Cell Immunity by Anti-DR5 Antibody TherapyJournal of Experimental Medicine, 2004
- Emerging Applications of the Tumor Necrosis Factor Family of Ligands and Receptors in Cancer TherapyJournal of Clinical Oncology, 2003
- Expression of TRAIL (TNF‐related apoptosis‐inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomasThe Journal of Pathology, 2003
- Targeting death and decoy receptors of the tumour-necrosis factor superfamilyNature Reviews Cancer, 2002
- Ectopic Expression of Bcl-2 and Bcl-xL Inhibits Apoptosis Induced by TNF-Related Apoptosis-Inducing Ligand (TRAIL) Through Suppression of Caspases-8, 7, and 3 and BID Cleavage in Human Acute Myelogenous Leukemia Cell Line HL-60Journal of Interferon & Cytokine Research, 2002
- Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin diseaseCancer, 2001
- TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2Oncogene, 2001
- Expression of tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors and sensitivity to TRAIL-induced apoptosis in primary B-cell acute lymphoblastic leukaemia cellsBritish Journal of Haematology, 2000
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995